Delivery Order SPE2DB20D1004-SPE2DB24FG5P0

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,111.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, and is designated as a Firm Fixed Price Delivery Order with a completion date of February 21, 2025. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAM77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a medication, and has a ceiling value of $2,002.00. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance runs through December 30, 2024. This contract appears to be part...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of CLOBAZAM 10 MG TABLET 100S. The fixed-price contract, valued at $5,120.24, has a completion date of September 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.93, is a delivery order for the supply of 4567222938 - CLOBAZAM 10 MG TABLET 100S. The contract has a completion date of February 11, 2025 and utilizes a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a for-profit organization registered in the System...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564689868 - CLOBAZAM 10 MG TABLET 100S. The contract is a Delivery Order with a Firm Fixed Price of $1,592.62 and an ultimate completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $5,110.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567582220 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of March 17, 2025. The contract is structured as a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract....
This federal contract award, with a ceiling value of $28,759.55, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565919941 CLOBAZAM 10 MG TABLET 100S, a prescription medication, to support U.S. federal government healthcare needs. This is a firm fixed-price delivery order contract with a completion date of September 25, 2024. The contract does not have a set-aside designation....
This federal contract award, valued at $10,978.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of June 4, 2024 and was awarded on June 3, 2024. This contract...
This federal contract award, valued at $8,044.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562592259 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of October 26, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program....
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUD22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,866.53 firm-fixed-price delivery order is for the supply of 4566924902 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG5P0
    Delivery Order

This federal contract award, ID SPE2DB20D1004|SPE2DB24FG5P0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565295207 CLOBAZAM 10 MG TABLET 100S, with a ceiling value of $1,741.38. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 31, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 1:27 PM